Evidence map›Paper›PMID 35846224›Full record

ArticleEJHaem2022

Cholecystectomy in a patient with paroxysmal nocturnal haemoglobinuria undergoing ravulizumab maintenance treatment.

Mitsuru Moriyama, Yasuo Aota, Masahiro Okabe, Yoshiaki Osaka, Seiichiro Katagiri, Daigo Akahane, Akihiko Gotoh

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in EJHaem, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mitsuru MoriyamaDepartment of Hematology Tokyo Medical University Tokyo Japan.
Yasuo AotaDepartment of Hematology Tokyo Medical University Tokyo Japan.
Masahiro OkabeDepartment of Internal Medicine Kohsei Chuo General Hospital Tokyo Japan.
Yoshiaki OsakaDeptartment of Gastrointestinal and General Surgery Kohsei Chuo General Hospital Tokyo Japan.
Seiichiro KatagiriDepartment of Hematology Tokyo Medical University Tokyo Japan.ORCID https://orcid.org/0000-0002-3031-9990
Daigo AkahaneDepartment of Hematology Tokyo Medical University Tokyo Japan.ORCID https://orcid.org/0000-0002-9295-1465
Akihiko GotohDepartment of Hematology Tokyo Medical University Tokyo Japan.ORCID https://orcid.org/0000-0002-8608-4393
Tokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 47-year-old male with paroxysmal nocturnal haemoglobinuria (PNH) controlled with routine ravulizumab administration suffered a massive haemolytic crisis due to choledocholithiasis. Laparoscopic cholecystectomy was performed 6 weeks after a regular ravulizumab infusion. After surgery, the patient presented with anaemia without marked elevation in lactate dehydrogenase and required two blood transfusions. Tumour necrosis factor-

Indexed as

cholecystectomyparoxysmal nocturnal haemoglobinuriaravulizumabtumour necrosis factor‐α

Identifiers

PMID35846224
PMCPMC9175661
OpenAlexW3213411304

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.